© 2020 MJH Life Sciences and HCPLive. All rights reserved.
August 07, 2020
The study paves the way for prospective multi-institutional randomized control trials to further re-enforce the safe use of direct oral anticoagulants in patients with obesity.
August 03, 2020
The most common adverse events were injection-site reactions and headaches.
July 31, 2020
A discussion on how thromboembolism research and care could benefit from progression in diagnostics.
July 30, 2020
The model can simulate treatment benefit over time with time-varying low-density lipoprotein cholesterol.
Patients with a mPAP of at least 19 mm Hg and pulmonary artery wedge pressure of 15 mm Hg or less had an adjusted hazard ratio for mortality of 1.71.
A new systematic review and meta-analysis challenges the notion that preventing VTE is associated reduced mortality risk.
July 24, 2020
New findings evidences the device commonly used treatment in patients with VTE—despite its association with potentially new DVT development or existing DVT propagation.
July 22, 2020
An expert explains why little progress has been made in disease prevalence and burden in the US.
July 20, 2020
A secondary ACCELERATE assessment shows a particular set of patients who may benefit from Lp(a)-lowering novel agents.